Environmental Factors-Induced Oxidative Stress: Hormonal and Molecular Pathway Disruptions in Hypogonadism and Erectile Dysfunction
Overview
Authors
Affiliations
Hypogonadism is an endocrine disorder characterized by inadequate serum testosterone production by the Leydig cells of the testis. It is triggered by alterations in the hypothalamic-pituitary-gonadal axis. Erectile dysfunction (ED) is another common disorder in men that involves an alteration in erectile response-organic, relational, or psychological. The incidence of hypogonadism and ED is common in men aged over 40 years. Hypogonadism (including late-onset hypogonadism) and ED may be linked to several environmental factors-induced oxidative stresses. The factors mainly include exposure to pesticides, radiation, air pollution, heavy metals and other endocrine-disrupting chemicals. These environmental risk factors may induce oxidative stress and lead to hormonal dysfunctions. To better understand the subject, the study used many keywords, including "hypogonadism", "late-onset hypogonadism", "testosterone", "erectile dysfunction", "reactive oxygen species", "oxidative stress", and "environmental pollution" in major online databases, such as SCOPUS and PUBMED to extract relevant scientific information. Based on these parameters, this review summarizes a comprehensive insight into the important environmental issues that may have a direct or indirect association with hypogonadism and ED in men. The study concludes that environmental factors-induced oxidative stress may cause infertility in men. The hypothesis and outcomes were reviewed critically, and the mechanistic approaches are applied through oxidant-sensitive pathways. This study also provides reccomendations on future therapeutic interventions and protective measures against such adverse environmental factors-induced hypogonadism and ED.
Xia W, Xie P, Zhuang Q, Zhang M, Shao N, Chen Y BMC Public Health. 2025; 25(1):939.
PMID: 40065268 PMC: 11892185. DOI: 10.1186/s12889-025-22194-5.
Liu J, Ma C, Leng Y, Qin J, Zhang P Sci Rep. 2025; 15(1):8040.
PMID: 40055483 PMC: 11889201. DOI: 10.1038/s41598-025-92934-5.
Olopade E, Adefegha S, Alao J, Adepoju A, Fakayode A, Oboh G Basic Clin Pharmacol Toxicol. 2025; 136(3):e70010.
PMID: 39960010 PMC: 11831715. DOI: 10.1111/bcpt.70010.
Zhang W, Qu R, Cheng G, Wang J, Yin T, Liu J Toxics. 2025; 13(1).
PMID: 39853037 PMC: 11769323. DOI: 10.3390/toxics13010039.
Exploring novel drug targets for erectile dysfunction through plasma proteome with genome.
Qiu Z, Cheng L, Wang Q, Dong Z Sex Med. 2025; 12(6):qfae091.
PMID: 39790564 PMC: 11710913. DOI: 10.1093/sexmed/qfae091.